297 related articles for article (PubMed ID: 25691157)
1. Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein.
Vu TT; Zhou J; Leslie BA; Stafford AR; Fredenburgh JC; Ni R; Qiao S; Vaezzadeh N; Jahnen-Dechent W; Monia BP; Gross PL; Weitz JI
Blood; 2015 Apr; 125(17):2712-9. PubMed ID: 25691157
[TBL] [Abstract][Full Text] [Related]
2. Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein.
Malik RA; Zhou J; Fredenburgh JC; Truong TK; Crosby JR; Revenko AS; Weitz JI
Blood Adv; 2021 Sep; 5(18):3540-3551. PubMed ID: 34474475
[TBL] [Abstract][Full Text] [Related]
3. Histidine-rich glycoprotein binds DNA and RNA and attenuates their capacity to activate the intrinsic coagulation pathway.
Vu TT; Leslie BA; Stafford AR; Zhou J; Fredenburgh JC; Weitz JI
Thromb Haemost; 2016 Jan; 115(1):89-98. PubMed ID: 26354857
[TBL] [Abstract][Full Text] [Related]
4. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
[TBL] [Abstract][Full Text] [Related]
5. Histidine-rich glycoprotein attenuates catheter thrombosis.
Malik RA; Liao P; Zhou J; Hussain R; Fredenburgh JC; Hettrick L; Revenko AS; Weitz JI
Blood Adv; 2023 Sep; 7(18):5651-5660. PubMed ID: 37042966
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
7. Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice.
Malik RA; Zhou J; Fredenburgh JC; Crosby J; Revenko AS; Healey JS; Weitz JI
Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1658-1670. PubMed ID: 38752349
[TBL] [Abstract][Full Text] [Related]
8. Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation.
MacQuarrie JL; Stafford AR; Yau JW; Leslie BA; Vu TT; Fredenburgh JC; Weitz JI
Blood; 2011 Apr; 117(15):4134-41. PubMed ID: 21304106
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
[TBL] [Abstract][Full Text] [Related]
10. Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding.
Cai TQ; Wu W; Shin MK; Xu Y; Jochnowitz N; Zhou Y; Hoos L; Bentley R; Strapps W; Thankappan A; Metzger JM; Ogletree ML; Tadin-Strapps M; Seiffert DA; Chen Z
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):893-902. PubMed ID: 26192114
[TBL] [Abstract][Full Text] [Related]
11. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
[TBL] [Abstract][Full Text] [Related]
12. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
[TBL] [Abstract][Full Text] [Related]
13. Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait.
Bird JE; Smith PL; Wang X; Schumacher WA; Barbera F; Revelli JP; Seiffert D
Thromb Haemost; 2012 Jun; 107(6):1141-50. PubMed ID: 22398951
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic potential of the contact activation pathway.
Schmaier AH
Curr Opin Hematol; 2016 Sep; 23(5):445-52. PubMed ID: 27380557
[TBL] [Abstract][Full Text] [Related]
15. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
16. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
17. Factor XII activation is essential to sustain the procoagulant effects of particulate matter.
Kilinç E; Van Oerle R; Borissoff JI; Oschatz C; Gerlofs-Nijland ME; Janssen NA; Cassee FR; Sandström T; Renné T; Ten Cate H; Spronk HM
J Thromb Haemost; 2011 Jul; 9(7):1359-67. PubMed ID: 21481175
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D; Renné T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
[TBL] [Abstract][Full Text] [Related]
19. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
